{"id":142058,"date":"2025-12-03T13:33:24","date_gmt":"2025-12-03T12:33:24","guid":{"rendered":"https:\/\/lavozdeibiza.com\/sin-categorizar\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/"},"modified":"2025-12-03T13:33:24","modified_gmt":"2025-12-03T12:33:24","slug":"the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro","status":"publish","type":"post","link":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/","title":{"rendered":"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro"},"content":{"rendered":"<p data-start=\"290\" data-end=\"823\">The <strong data-start=\"293\" data-end=\"335\">World Health Organization (WHO)<\/strong> has taken a crucial step on Monday in the global fight against obesity: for the first time it officially endorses the use of <strong data-start=\"471\" data-end=\"480\">GLP-1<\/strong> drugs, marketed as <strong data-start=\"503\" data-end=\"533\">Ozempic, Wegovy or Mounjaro<\/strong>, for the long-term treatment of chronic obesity in adults. The decision places these drugs, initially created to treat diabetes, at the center of a global health strategy that seeks to curb a disease that already affects <strong data-start=\"787\" data-end=\"822\">more than one billion people<\/strong>. <\/p>\n<p data-start=\"825\" data-end=\"1266\">GLP-1s act by mimicking a hormone that influences insulin secretion and satiety, which has been shown to be key to both diabetes control and weight loss. &#8220;<strong data-start=\"1033\" data-end=\"1099\">Obesity is one of the great global health challenges<\/strong>,&#8221; stressed WHO Director <strong data-start=\"1133\" data-end=\"1163\">Tedros Adhanom Ghebreyesus<\/strong> as he presented the new recommendations, which formalize what is already a growing clinical trend.<\/p>\n<h2 data-start=\"1273\" data-end=\"1344\"><strong data-start=\"1277\" data-end=\"1344\">GLP-1: an effective tool in the face of a global health crisis<\/strong><\/h2>\n<p data-start=\"1346\" data-end=\"1693\">The latest WHO data show an alarming reality: <strong data-start=\"1407\" data-end=\"1459\">more than 3.7 million people died in 2024<\/strong> from obesity-related diseases, and projections suggest that the number of people affected could <strong data-start=\"1575\" data-end=\"1603\">double by 2030<\/strong>. Against this backdrop, the organization believes that GLP-1s will be an indispensable support. <\/p>\n<p data-start=\"1695\" data-end=\"1915\">&#8220;<strong data-start=\"1696\" data-end=\"1897\">While drugs alone will not solve this global health crisis, GLP-1 treatments can help millions of people overcome obesity and reduce the associated harms<\/strong>,&#8221; Tedros stressed.<\/p>\n<ul>\n<li>\n<h5><a href=\"https:\/\/lavozdeibiza.com\/actualidad\/que-es-el-orfoglipron-y-que-diferencia-tiene-con-el-ozempic\/?swcfpc=1\">What is Orforglipron and how does it differ from Ozempic?<\/a><\/h5>\n<\/li>\n<\/ul>\n<p data-start=\"1917\" data-end=\"2119\">The guidelines recommend the use of these drugs in adults (except pregnant women) as <strong data-start=\"2014\" data-end=\"2043\">long-term treatment<\/strong>, an important qualification that recognizes the chronic nature of obesity.<\/p>\n<h2 data-start=\"2126\" data-end=\"2204\"><strong data-start=\"2130\" data-end=\"2204\">No &#8220;magic bullet&#8221;: WHO calls for caution and comprehensive approach<\/strong><\/h2>\n<p data-start=\"2206\" data-end=\"2332\">While welcoming the proven efficacy of Ozempic, Wegovy or Mounjaro, WHO insists that they should not be seen as an easy shortcut. The agency warns that, despite their results, information on <strong data-start=\"2417\" data-end=\"2465\">their long-term safety and effectiveness<\/strong> is still lacking. Obesity, it recalls, is &#8220;a complex and chronic disease,&#8221; closely related to pathologies such as <strong data-start=\"2576\" data-end=\"2646\">cardiovascular disease, type 2 diabetes and some types of cancer<\/strong>.  <\/p>\n<p data-start=\"2649\" data-end=\"2818\">For this reason, WHO stresses the need to combine GLP-1s with <strong data-start=\"2713\" data-end=\"2754\">a healthy diet, physical activity<\/strong> and public policies that generate &#8220;<strong data-start=\"2789\" data-end=\"2816\">healthier environments<\/strong>.&#8221; &#8220;<strong data-start=\"2821\" data-end=\"2887\">You can&#8217;t look at these drugs as a magic bullet<\/strong>,&#8221; <strong data-start=\"2907\" data-end=\"2924\">Jeremy Farrar<\/strong>, WHO assistant director general, told AFP. &#8220;<strong data-start=\"2958\" data-end=\"3071\">But it is clear that they are going to become a very important part of an integrated approach to obesity<\/strong>.&#8221;<\/p>\n<h2 data-start=\"3080\" data-end=\"3152\"><strong data-start=\"3084\" data-end=\"3152\">&#8220;Changing the epidemiological trajectory&#8221;: a before and an after<\/strong><\/h2>\n<p data-start=\"3154\" data-end=\"3362\">The potential impact of GLP-1s goes beyond individual health. According to the WHO, <strong data-start=\"3238\" data-end=\"3336\">the global economic cost of obesity could reach $3 billion annually<\/strong> by the end of this decade. <\/p>\n<p data-start=\"3364\" data-end=\"3630\">&#8220;<strong data-start=\"3365\" data-end=\"3460\">There is a possibility that we can change the epidemiological trajectory of obesity<\/strong>,&#8221; said WHO senior advisor <strong data-start=\"3502\" data-end=\"3524\">Francesca Celletti<\/strong>. If that curve does not change, Farrar warned, &#8220;<strong data-start=\"3568\" data-end=\"3628\">the pressure on health systems will be unsustainable<\/strong>.&#8221; <\/p>\n<h2 data-start=\"3637\" data-end=\"3704\"><strong data-start=\"3641\" data-end=\"3704\">The big challenge: access to LPG-1 and the poorest countries<\/strong><\/h2>\n<p data-start=\"3706\" data-end=\"3943\">Despite their efficacy, these drugs face a decisive obstacle: their <strong data-start=\"3780\" data-end=\"3802\">prohibitive price<\/strong>. The WHO recognizes the risk of putting GLP-1s beyond the reach of the poorest countries, where the health impact could be enormous. This is compounded by the current shortage, which has particularly affected diabetes patients, for whom these drugs were originally developed.  <\/p>\n<ul>\n<li>\n<h5><a href=\"https:\/\/lavozdeibiza.com\/baleares\/las-farmacias-de-baleares-siguen-sin-suficiente-ozempic-y-alertan-de-su-uso-indebido-para-perder-peso\/?swcfpc=1\">Balearic pharmacies still not enough Ozempic and warn of its improper use for weight loss<\/a><\/h5>\n<\/li>\n<\/ul>\n<p data-start=\"4106\" data-end=\"4378\">In September, the organization included them on its <strong data-start=\"4155\" data-end=\"4191\">list of essential medicines<\/strong>, a strategic move to promote the production of <strong data-start=\"4250\" data-end=\"4284\">affordable generic versions<\/strong>. Its goal is clear: to ensure that GLP-1s do not become an exclusive treatment. <\/p>\n<h2 data-start=\"4385\" data-end=\"4441\"><strong data-start=\"4389\" data-end=\"4441\">A new chapter in the fight against obesity<\/strong><\/h2>\n<p data-start=\"4443\" data-end=\"4725\">The WHO endorsement marks a turning point in the approach to obesity, considering for the first time that it can and should also be treated with advanced pharmacological tools. But the message is unequivocal: GLP-1s are a powerful aid, yes, but not a unique prescription. <\/p>\n<p data-start=\"4727\" data-end=\"5031\" data-is-last-node=\"\" data-is-only-node=\"\">Faced with a disease that is advancing unchecked, the WHO is committed to a multiple strategy that combines <strong data-start=\"4828\" data-end=\"4891\">medication, healthy lifestyles and public policies<\/strong>. And on this path, Ozempic, Wegovy and Mounjaro are beginning to play a leading role that could transform global health in this decade. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>WHO publishes its first guidelines for treating chronic obesity in adults with GLP-1 and warns: effective, but not a &#8220;magic bullet&#8221;<\/p>\n","protected":false},"author":32,"featured_media":142021,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[2910,3287],"tags":[9972,9512,9971,9970],"ppma_author":[6611],"class_list":["post-142058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-current-news","category-society","tag-obesity","tag-ozempic","tag-who","tag-world-health-organization"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro - La Voz De Ibiza<\/title>\n<meta name=\"description\" content=\"WHO publishes its first guidelines for treating chronic obesity in adults with GLP-1 and warns: effective, but not a &quot;magic bullet&quot;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro - La Voz De Ibiza\" \/>\n<meta property=\"og:description\" content=\"WHO publishes its first guidelines for treating chronic obesity in adults with GLP-1 and warns: effective, but not a &quot;magic bullet&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/\" \/>\n<meta property=\"og:site_name\" content=\"La Voz De Ibiza\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-03T12:33:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1220\" \/>\n\t<meta property=\"og:image:height\" content=\"813\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Marianel Battaglia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@vozdeibiza\" \/>\n<meta name=\"twitter:site\" content=\"@vozdeibiza\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marianel Battaglia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/\"},\"author\":{\"name\":\"Marianel Battaglia\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#\/schema\/person\/929bae173f9ebdac3b761950ecd4e6f0\"},\"headline\":\"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro\",\"datePublished\":\"2025-12-03T12:33:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/\"},\"wordCount\":695,\"publisher\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp\",\"keywords\":[\"Obesity\",\"Ozempic\",\"WHO\",\"World Health Organization\"],\"articleSection\":[\"CURRENT NEWS\",\"SOCIETY\"],\"inLanguage\":\"en-US\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/\",\"url\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/\",\"name\":\"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro - La Voz De Ibiza\",\"isPartOf\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp\",\"datePublished\":\"2025-12-03T12:33:24+00:00\",\"description\":\"WHO publishes its first guidelines for treating chronic obesity in adults with GLP-1 and warns: effective, but not a \\\"magic bullet\\\"\",\"breadcrumb\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#primaryimage\",\"url\":\"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp\",\"contentUrl\":\"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp\",\"width\":1220,\"height\":813,\"caption\":\"Ozempic\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/lavozdeibiza.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#website\",\"url\":\"https:\/\/lavozdeibiza.com\/en\/\",\"name\":\"La Voz de Ibiza\",\"description\":\"Diario de informaci\u00f3n actualidad y noticias de Ibiza. Todas las noticias de los municipios de Ibiza\",\"publisher\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lavozdeibiza.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"NewsMediaOrganization\"],\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#organization\",\"name\":\"La Voz de Ibiza\",\"url\":\"https:\/\/lavozdeibiza.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2023\/10\/logo-lvib-grande.jpg\",\"contentUrl\":\"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2023\/10\/logo-lvib-grande.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"La Voz de Ibiza\"},\"image\":{\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/vozdeibiza\",\"https:\/\/www.instagram.com\/lavozibiza\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#\/schema\/person\/929bae173f9ebdac3b761950ecd4e6f0\",\"name\":\"Marianel Battaglia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/34a286aabf1ec20ddd3421883a350bf413ea1c629a017fb843ff424238d96433?s=96&d=mm&r=g3ec01433967ecfa17bedc95e381a134e\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34a286aabf1ec20ddd3421883a350bf413ea1c629a017fb843ff424238d96433?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34a286aabf1ec20ddd3421883a350bf413ea1c629a017fb843ff424238d96433?s=96&d=mm&r=g\",\"caption\":\"Marianel Battaglia\"},\"url\":\"https:\/\/lavozdeibiza.com\/en\/author\/mbattaglia\/\"},{\"@type\":\"SiteNavigationElement\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#site-navigation\",\"cssSelector\":[\".cib-main-menu\"]},{\"@type\":\"WPHeader\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#header\",\"cssSelector\":[\".cib-header\"]},{\"@type\":\"WPFooter\",\"@id\":\"https:\/\/lavozdeibiza.com\/en\/#footer\",\"cssSelector\":[\".cib-footer\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro - La Voz De Ibiza","description":"WHO publishes its first guidelines for treating chronic obesity in adults with GLP-1 and warns: effective, but not a \"magic bullet\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/","og_locale":"en_US","og_type":"article","og_title":"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro - La Voz De Ibiza","og_description":"WHO publishes its first guidelines for treating chronic obesity in adults with GLP-1 and warns: effective, but not a \"magic bullet\"","og_url":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/","og_site_name":"La Voz De Ibiza","article_published_time":"2025-12-03T12:33:24+00:00","og_image":[{"width":1220,"height":813,"url":"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp","type":"image\/webp"}],"author":"Marianel Battaglia","twitter_card":"summary_large_image","twitter_creator":"@vozdeibiza","twitter_site":"@vozdeibiza","twitter_misc":{"Written by":"Marianel Battaglia","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#article","isPartOf":{"@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/"},"author":{"name":"Marianel Battaglia","@id":"https:\/\/lavozdeibiza.com\/en\/#\/schema\/person\/929bae173f9ebdac3b761950ecd4e6f0"},"headline":"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro","datePublished":"2025-12-03T12:33:24+00:00","mainEntityOfPage":{"@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/"},"wordCount":695,"publisher":{"@id":"https:\/\/lavozdeibiza.com\/en\/#organization"},"image":{"@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#primaryimage"},"thumbnailUrl":"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp","keywords":["Obesity","Ozempic","WHO","World Health Organization"],"articleSection":["CURRENT NEWS","SOCIETY"],"inLanguage":"en-US"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/","url":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/","name":"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro - La Voz De Ibiza","isPartOf":{"@id":"https:\/\/lavozdeibiza.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#primaryimage"},"image":{"@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#primaryimage"},"thumbnailUrl":"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp","datePublished":"2025-12-03T12:33:24+00:00","description":"WHO publishes its first guidelines for treating chronic obesity in adults with GLP-1 and warns: effective, but not a \"magic bullet\"","breadcrumb":{"@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#primaryimage","url":"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp","contentUrl":"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2025\/12\/17647468194210.webp","width":1220,"height":813,"caption":"Ozempic"},{"@type":"BreadcrumbList","@id":"https:\/\/lavozdeibiza.com\/en\/society\/the-drugs-that-will-change-the-fight-against-obesity-who-backs-ozempic-wegovy-and-mounjaro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/lavozdeibiza.com\/en\/"},{"@type":"ListItem","position":2,"name":"The drugs that will change the fight against obesity: WHO backs Ozempic, Wegovy and Mounjaro"}]},{"@type":"WebSite","@id":"https:\/\/lavozdeibiza.com\/en\/#website","url":"https:\/\/lavozdeibiza.com\/en\/","name":"La Voz de Ibiza","description":"Diario de informaci\u00f3n actualidad y noticias de Ibiza. Todas las noticias de los municipios de Ibiza","publisher":{"@id":"https:\/\/lavozdeibiza.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lavozdeibiza.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","NewsMediaOrganization"],"@id":"https:\/\/lavozdeibiza.com\/en\/#organization","name":"La Voz de Ibiza","url":"https:\/\/lavozdeibiza.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lavozdeibiza.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2023\/10\/logo-lvib-grande.jpg","contentUrl":"https:\/\/lavozdeibiza.com\/wp-content\/uploads\/2023\/10\/logo-lvib-grande.jpg","width":1500,"height":1000,"caption":"La Voz de Ibiza"},"image":{"@id":"https:\/\/lavozdeibiza.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/vozdeibiza","https:\/\/www.instagram.com\/lavozibiza\/"]},{"@type":"Person","@id":"https:\/\/lavozdeibiza.com\/en\/#\/schema\/person\/929bae173f9ebdac3b761950ecd4e6f0","name":"Marianel Battaglia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34a286aabf1ec20ddd3421883a350bf413ea1c629a017fb843ff424238d96433?s=96&d=mm&r=g3ec01433967ecfa17bedc95e381a134e","url":"https:\/\/secure.gravatar.com\/avatar\/34a286aabf1ec20ddd3421883a350bf413ea1c629a017fb843ff424238d96433?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34a286aabf1ec20ddd3421883a350bf413ea1c629a017fb843ff424238d96433?s=96&d=mm&r=g","caption":"Marianel Battaglia"},"url":"https:\/\/lavozdeibiza.com\/en\/author\/mbattaglia\/"},{"@type":"SiteNavigationElement","@id":"https:\/\/lavozdeibiza.com\/en\/#site-navigation","cssSelector":[".cib-main-menu"]},{"@type":"WPHeader","@id":"https:\/\/lavozdeibiza.com\/en\/#header","cssSelector":[".cib-header"]},{"@type":"WPFooter","@id":"https:\/\/lavozdeibiza.com\/en\/#footer","cssSelector":[".cib-footer"]}]}},"authors":[{"term_id":6611,"user_id":32,"is_guest":0,"slug":"mbattaglia","display_name":"Marianel Battaglia","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/34a286aabf1ec20ddd3421883a350bf413ea1c629a017fb843ff424238d96433?s=96&d=mm&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":"","9":"","10":""}],"_links":{"self":[{"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/posts\/142058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/comments?post=142058"}],"version-history":[{"count":0,"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/posts\/142058\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/media\/142021"}],"wp:attachment":[{"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/media?parent=142058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/categories?post=142058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/tags?post=142058"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/lavozdeibiza.com\/en\/wp-json\/wp\/v2\/ppma_author?post=142058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}